General Information of Drug (ID: DMZQBCL)

Drug Name
LR3001 Drug Info
Indication
Disease Entry ICD 11 Status REF
Myeloid leukaemia 2B33.1 Phase 2 [1]
Therapeutic Class
Anticancer Agents
Cross-matching ID
TTD Drug ID
DMZQBCL

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Myb messenger RNA (MYB mRNA) TT8V13P MYB_HUMAN Not Available [2]

References

1 Pipeline report of Genta.
2 Genta obtains orphan drug designation for C-Myb Antisense (LR3001) in chronic myelocytic leukemia. Genta. 2005.